Federal contract award
N0042121F3005
CT&E REQUIREMENT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | NAVAL AIR WARFARE CENTER AIR DIV |
| NAICS | 541330 — Engineering Services |
| PSC | U008 — Training/Curriculum Development |
| Parent award / vehicle | N0017819D7206 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $6.4M |
| Current contract value | $10.7M |
| Potential contract value / ceiling | $11.6M |
| Start date | May 20, 2021 |
| Current end date | Dec 1, 2026 |
| Potential end date | Dec 1, 2026 |
| Latest award activity | Apr 20, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 36 of 36 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 20, 2026 | P00035 | $102.0K | THE PURPOSE OF THIS MODIFICATION IS TO COMPLETED FIRST EPS CLEAN UP MOD, INCREMENTAL FUND, AND REALIGN CEILING |
| Feb 5, 2026 | P00034 | $-41.4K | TO DE OBLIGATE FUNDING |
| Dec 11, 2025 | P00033 | $185.0K | PROVIDE FUNDING TO CLIN 6001 $100,000.00, CLIN 6001 $40,000.00, AND CLIN 6005 IN THE AMOUNT OF $ 45,000.00. PMT# N00421-26-NORFP-AN10000/AN1000M-0066 PMT# N00421-26-NORFP-AN10000/AN1000M-0111 |
| Nov 5, 2025 | P00032 | $34.0K | THE PURPOSE OF THIS MODIFICATION IS TO ADD FUNDING TO CLIN 6001 ON OPY4 IN THE AMOUNT OF $34,000.00. PMT# N00421-26-NORFP-AN10000/AN1000M-0045 |
| Sep 29, 2025 | P00031 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO DE OBLIGATE CEILING AND FUNDING FROM OPY3 CLIN 2307 IN THE AMOUNT OF $24,252.84, AND CREATE AND FUND NEW CLIN 6007 ON OPY4 IN THE AMOUNT OF $24,252.84. PMT# N00421-25-NORFP-CSSCPO-0084 |
| Sep 10, 2025 | P00030 | $66.2K | THE PURPOSE OF THIS MODIFICATION IS TO FUND CLIN 7000 IN THE AMOUNT OF $46,157.10, CLIN 2301 IN THE AMOUNT OF $19,000.00 AND CLIN 3300 IN THE AMOUNT OF $1,000.00 PMT# N00421-25-NORFP-51000MA-0363 PMT# N00421-25-NORFP-AN10000/AN1000M-0446 |
| Jun 18, 2025 | P00029 | $491.7K | THE PURPOSE OF P00029 IS TO INCREMENTALLY FUND CLINS 6003 AND 7001 IN THE AMOUNT OF $491,726.40. |
| Jun 10, 2025 | P00028 | $235.0K | THE PURPOSE OF P00028 IS TO EXERCISE CLINS 6000, 6001, 6003, 6005, 6006, 7000, AND 7001 WITH A PERIOD OF PERFORMANCE OF 16 JUNE 2025 - 15 JUNE 2026. P00028 ALSO INCREMENTALLY FUNDS CLINS 6001, 6005, AND 7000 IN THE AMOUNT OF $235,000.00. |
| Apr 14, 2025 | P00027 | $45.0K | THE PURPOSE OF P00027 IS TO INCREMENTALLY FUND CLINS 2301 AND 3300. THIS MODIFICATION REMOVES CLAUSES 52.222-21, 52.222-26, & 52.222-29 AND ADDS 52.240-1 TO COMPLY WITH RECENT EXECUTIVE ORDERS. |
| Jan 28, 2025 | P00026 | $97.1K | THE PURPOSE OF P00026 IS TO INCREMENTALLY FUND CLIN 2307. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Jan 23, 2025 | P00025 | $292.4K | THE PURPOSE OF P00025 IS TO CREATE NEW CPFF LABOR CLIN 2307. IN ADDITION, THIS MODIFICATION INCREMENTALLY FUNDS CLINS 2301, 2305, & 3300. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Sep 24, 2024 | P00024 | $20.8K | THE PURPOSE OF P00024 IS TO INCREMENTALLY FUND CLIN 2303. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Sep 23, 2024 | P00023 | $132.5K | THE PURPOSE OF P00023 IS TO DEOBLIGATE FUNDS FROM CLIN 2203 AND REOBLIGATE THEM TO CLIN 2303.THIS MODIFICATION PROVIDES INCREMENTAL FUNDING FOR CLINS 2301 & 3300. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Jun 12, 2024 | P00022 | $528.3K | THE PURPOSE OF P00022 IS TO: 1. TO OBLIGATE FUNDING ON CLIN 2303 & CLIN 3301. 2. TO EXERCISE CLIN 2301 BY FUNDING, CLIN 3300 AND CLIN 2305. THESE EXERCISES ARE IN ACCORDANCE WITH PMT PID N00421-24-NORFP-51000MA-0277. |
| May 23, 2024 | P00021 | $77.5K | THE PURPOSE OF P00021 IS TO INCREMENTALLY FUND CLINS 2201 & 3200. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Apr 29, 2024 | P00020 | $22.0K | THE PURPOSE OF P00020 IS TO INCREMENTALLY FUND CLIN 2205. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Feb 28, 2024 | P00019 | $133.0K | THE PURPOSE OF P00019 IS TO REALIGN CEILING ON CLINS 3001, 3001, 3100, AND 3002. THIS MODIFICATION ALSO INCREMENTALLY FUNDS CLINS 2201 AND 3200. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Feb 12, 2024 | P00018 | $30.0K | THE PURPOSE OF P00018 IS TO INCREMENTALLY FUND CLIN 2205 IN THE AMOUNT OF $30,000. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Dec 6, 2023 | P00017 | $100.0K | THE PURPOSE OF P00017 IS TO INCREMENTALLY FUND CLIN 2201 IN THE AMOUNT OF $100,000. IN ADDITION, THIS MODIFICATION REALIGNS FUNDING FROM CLIN 2203 TO 3201. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Oct 18, 2023 | P00016 | $101.0K | THE PURPOSE OF P00016 IS TO INCREMENTALLY FUND CLINS 3200 AND 2201. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Sep 27, 2023 | P00015 | $150.0K | THE PURPOSE OF P00015 IS TO INCREMENTALLY FUND CLIN 2203. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Sep 12, 2023 | P00014 | $24.9K | THE PURPOSE OF P00014 IS TO INCREMENTALLY FUND CLIN 3200. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Sep 11, 2023 | P00013 | $340.8K | THE PURPOSE OF P00013 IS TO INCREMENTALLY FUND CLIN 2203. THIS MODIFICATION ALSO DEOBLIGATES FUNDS FROM 3100 04 AND REOBLIGATES IT TO CLIN 3200. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Aug 14, 2023 | P00012 | $20.0K | THE PURPOSE OF P00012 IS TO INCREMENTALLY FUND CLIN 3100 AND TO REALIGN CEILING FROM CLIN 3101 TO 3100. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Jul 25, 2023 | P00011 | $73.9K | THE PURPOSE OF P00011 IS TO EXERCISE AND INCREMENTALLY FUND CLIN 2200. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Jun 15, 2023 | P00010 | $44.5K | THE PURPOSE OF P00010 IS TO EXERCISE AND INCREMENTALLY FUND CLIN 2205. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Jun 9, 2023 | P00009 | $-50.0K | THE PURPOSE OF P00009 IS TO EXERCISE OPTION YEAR 2 CLINS. IN ADDITION, THIS MODIFICATION REALIGNS FUNDING FROM CLIN 2101 TO CLIN 3100, AND DEOBLIGATES FUNDING FROM 2103 01. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Apr 24, 2023 | P00008 | $19.1K | THE PURPOSE OF P00008 IS TO INCREMENTALLY FUND CLIN 3100. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Nov 9, 2022 | P00007 | $326.7K | THE PURPOSE OF P00007 IS TO INCREMENTALLY FUND CLINS 2101 AND 3100. IN ADDITION, EXPIRED FUNDING ON CLIN 200301 IS DEOBLIGATED. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Aug 3, 2022 | P00006 | $619.0K | THE PURPOSE OF P00006 IS TO CORRECT THE ACRNS ASSIGNED UNDER SUBCLINS 2102 01, 2102 02, 2103 01, 3100 01, 3101 01 DUE TO DISCREPANCY UNDER CDR # CN109357. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED. |
| Jun 29, 2022 | P00005 | $18.2K | THE PURPOSE OF P00005 IS TO INCREMENTALLY FUND OYI CLINS. P00005 ALSO DEOBLIGATES FUNDING FROM BASE YEAR CLINS. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Jun 7, 2022 | P00004 | $75.0K | THE PURPOSE OF P00004 IS TO EXERCISE OPTION YEAR I. P00004 ALSO INCREMENTALLY FUNDS CLIN 2101. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Dec 20, 2021 | P00003 | $300.0K | THE PURPOSE OF P00003 IS TO INCREMENTALLY FUND CLINS 2001 & 3000. ADDITIONALLY, THIS MODIFICATION ADDS WILLIAM DENENEA AS THE ACOR. FINALLY, THIS MODIFICATION UPDATES CLAUSES 5252.201-9501 & 5252.242-9511. |
| Sep 7, 2021 | P00002 | $-207.0K | THE PURPOSE OF P00002 IS TO DEOBLIGATE FUNDING FROM ACRN AD ON CLIN 2003 BY $207,000.00. TO ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| Jun 29, 2021 | P00001 | $996.6K | THE PURPOSE OF P00001 IS TO INCREMENTALLY FUND CLINS 2002, 2003, & 3001. IN ADDITION, THE MODIFICATION REMOVES THE SPECIAL PAYMENT CLAUSE AND ADDS IN THE G-TXT-PAY CLAUSE. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED AND IN FULL FORCE AND EFFECT. |
| May 20, 2021 | 0 | $420.9K | CT&E REQUIREMENT |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2026-12-01 (37 days from calculation)
- +35 points
- 2 historical awards in this buyer and category group
- +10 points
- 36 recorded award transactions
- +10 points
- Latest award action: 2026-04-20
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.